Home Subscription Services
 
   

 
Quintessence International
QI Home Page
About the Editor
Editorial Board
Accepted Manuscripts
Submit
Author Guidelines
Submission Form
Reprints / Articles
Permissions
Advertising
MEDLINE Search
 
 
 
 
 
FacebookTwitter
Quintessence Publishing: Journals: QI
Quintessence International

Edited by Eli Eliav

ISSN 0033-6572 (print) • ISSN 1936-7163 (online)

Publication:
March 2007
Volume 38 , Issue 3

Back
Share Abstract:

Oral health and dental treatment of patients with renal disease

Maarit Vesterinen, DDS, MD / Hellevi Ruokonen, DDS, PhD, MSc / Tomi Leivo, MD, PhD / Ann-Marie Honkanen, DDS / Eero Honkanen, MD, PhD / Kirsti Kari, MSc / Christian Lindqvist, DDS, MD, PhD / Jukka H. Meurman, MD, PhD, D Odont

Pages: 211–219
PMID: 17333998

Objectives: To outline aspects that need consideration in the dental office when treating patients with renal disease and to present data on the oral health parameters of patients during the different phases of their renal disease during a 10-year follow-up period. Differences in clinical and salivary study parameters during the course of treatment of the renal disease were expected to occur. Method and Materials: Altogether, 39 patients with chronic renal failure were examined for dental health. Nine patients (mean age 50.8 years) were followed for 10 years through predialysis, dialysis, and posttransplant stages. The patients were examined clinically and radiographically and by analyzing the biochemical constituents of saliva. Patients’ perceptions of oral health were recorded using structured questionnaires. Results: No statistically significant differences were observed in the clinical parameters studied during the follow-up period. However, analyses of saliva components after renal transplantation showed significant improvement compared with components found during the predialysis stage. For example, median salivary albumin concentration, which describes the leakage of serum components to saliva, was 399 µg/mL at the predialysis stage, 353 µg/mL at the dialysis stage, and 181 µg/mL at the posttransplant stage. Conclusions: From the oral health point of view, the outcome was better than anticipated. The lower salivary albumin values after kidney transplantation may reflect the improvement of patients’ health during the course of the treatment. (Quintessence Int 2007;38:211–219)

Key words: dental health, dialysis, kidney transplant, oral health, predialysis, saliva

Full Text PDF File | Order Article

 

Get Adobe Reader
Adobe Acrobat Reader is required to view PDF files. This is a free program available from the Adobe web site.
Follow the download directions on the Adobe web site to get your copy of Adobe Acrobat Reader.
  © 2014 Quintessence Publishing Co Inc
 

Home | Subscription Services | Books | Journals | Multimedia | Events | Blog
Terms of Use | Privacy Policy | About Us | Contact Us | Advertising | Help | Sitemap | Catalog